150 related articles for article (PubMed ID: 30712469)
1. Application of Circulation Tumor Cells Detection in Diagnosis and Treatment of Breast Tumors.
Cai F; Cen C; Cai L; Falar Luis MA; Biskup E
Rejuvenation Res; 2019 Dec; 22(6):498-502. PubMed ID: 30712469
[TBL] [Abstract][Full Text] [Related]
2. Circulating tumor cells in breast cancer: applications in personalized medicine.
Lee JS; Magbanua MJM; Park JW
Breast Cancer Res Treat; 2016 Dec; 160(3):411-424. PubMed ID: 27761678
[TBL] [Abstract][Full Text] [Related]
3. Advances in liquid biopsy using circulating tumor cells and circulating cell-free tumor DNA for detection and monitoring of breast cancer.
Zhang X; Ju S; Wang X; Cong H
Clin Exp Med; 2019 Aug; 19(3):271-279. PubMed ID: 31190187
[TBL] [Abstract][Full Text] [Related]
4. Clinical Relevance and Therapeutic Application of CTCs in Advanced Breast Cancer.
Cueva Bañuelos JF; Rodríguez López C; Cortegoso Mosquera A; Palacios Ozores P; Curiel García T
Adv Exp Med Biol; 2020; 1220():147-164. PubMed ID: 32304085
[TBL] [Abstract][Full Text] [Related]
5. Circulating Tumor Cells in Breast Cancer.
Liang DH; Hall C; Lucci A
Recent Results Cancer Res; 2020; 215():127-145. PubMed ID: 31605227
[TBL] [Abstract][Full Text] [Related]
6. The Potential of Circulating Tumor Cells in Personalized Management of Breast Cancer: A Systematic Review.
Khatami F; Aghayan HR; Sanaei M; Heshmat R; Tavangar SM; Larijani B
Acta Med Iran; 2017 Mar; 55(3):175-193. PubMed ID: 28282718
[TBL] [Abstract][Full Text] [Related]
7. Circulating tumor cells in breast cancer--current status and perspectives.
Banys-Paluchowski M; Krawczyk N; Meier-Stiegen F; Fehm T
Crit Rev Oncol Hematol; 2016 Jan; 97():22-9. PubMed ID: 26563820
[TBL] [Abstract][Full Text] [Related]
8. Disseminated tumor cells in bone marrow and circulating tumor cells in blood of breast cancer patients: current state of detection and characterization.
Riethdorf S; Pantel K
Pathobiology; 2008; 75(2):140-8. PubMed ID: 18544969
[TBL] [Abstract][Full Text] [Related]
9. Circulating tumor cells in breast cancer.
Banys M; Müller V; Melcher C; Aktas B; Kasimir-Bauer S; Hagenbeck C; Hartkopf A; Fehm T
Clin Chim Acta; 2013 Aug; 423():39-45. PubMed ID: 23623805
[TBL] [Abstract][Full Text] [Related]
10. Circulating tumor cells in breast cancer: detection systems, molecular characterization, and future challenges.
Lianidou ES; Markou A
Clin Chem; 2011 Sep; 57(9):1242-55. PubMed ID: 21784769
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of circulating tumor cells in breast cancer patients.
Tao M; Ma D; Li Y; Zhou C; Li Y; Zhang Y; Duan W; Xu X; Wang R; Wu L; Liu H
Breast Cancer Res Treat; 2011 Aug; 129(1):247-54. PubMed ID: 21512769
[TBL] [Abstract][Full Text] [Related]
12. Detection of circulating tumor cells during follow-up of patients with early breast cancer: Clinical utility for monitoring of therapy efficacy.
Mikulová V; Cabiňaková M; Janatková I; Mestek O; Zima T; Tesařová P
Scand J Clin Lab Invest; 2014 Mar; 74(2):132-42. PubMed ID: 24350991
[TBL] [Abstract][Full Text] [Related]
13. Towards a personalized breast cancer treatment approach guided by circulating tumor cell (CTC) characteristics.
Onstenk W; Gratama JW; Foekens JA; Sleijfer S
Cancer Treat Rev; 2013 Nov; 39(7):691-700. PubMed ID: 23683721
[TBL] [Abstract][Full Text] [Related]
14. Are Circulating Tumor Cells (CTCs) Ready for Clinical Use in Breast Cancer? An Overview of Completed and Ongoing Trials Using CTCs for Clinical Treatment Decisions.
Schochter F; Friedl TWP; deGregorio A; Krause S; Huober J; Rack B; Janni W
Cells; 2019 Nov; 8(11):. PubMed ID: 31717458
[TBL] [Abstract][Full Text] [Related]
15. Biological and Molecular Characterization of Circulating Tumor Cells: A Creative Strategy for Precision Medicine?
Chen S; El-Heliebi A; Kroneis T
Adv Clin Chem; 2017; 82():71-103. PubMed ID: 28939214
[TBL] [Abstract][Full Text] [Related]
16. Clinical indications for, and the future of, circulating tumor cells.
Moon DH; Lindsay DP; Hong S; Wang AZ
Adv Drug Deliv Rev; 2018 Feb; 125():143-150. PubMed ID: 29626548
[TBL] [Abstract][Full Text] [Related]
17. Detection of circulating tumor cells using manually performed immunocytochemistry (MICC) does not correlate with outcome in patients with early breast cancer - Results of the German SUCCESS-A- trial.
Jueckstock J; Rack B; Friedl TW; Scholz C; Steidl J; Trapp E; Tesch H; Forstbauer H; Lorenz R; Rezai M; Häberle L; Alunni-Fabbroni M; Schneeweiss A; Beckmann MW; Lichtenegger W; Fasching PA; Pantel K; Janni W;
BMC Cancer; 2016 Jul; 16():401. PubMed ID: 27387743
[TBL] [Abstract][Full Text] [Related]
18. Detection of circulating tumor cells in patients with breast cancer using the quantitative RT-PCR assay for monitoring of therapy efficacy.
Wang HY; Ahn S; Kim S; Park S; Park S; Han H; Sohn JH; Kim S; Lee H
Exp Mol Pathol; 2014 Dec; 97(3):445-52. PubMed ID: 25217799
[TBL] [Abstract][Full Text] [Related]
19. Circulating tumor cells in the clinical cancer diagnosis.
Zhang P; Zhou H; Lu K; Wang Y; Feng T
Clin Transl Oncol; 2020 Mar; 22(3):279-282. PubMed ID: 31140068
[TBL] [Abstract][Full Text] [Related]
20. Serum IGF-1, IGFBP-3 levels and circulating tumor cells (CTCs) in early breast cancer patients.
Papadakis GZ; Mavroudis D; Georgoulias V; Souglakos J; Alegakis AK; Samonis G; Bagci U; Makrigiannakis A; Zoras O
Growth Horm IGF Res; 2017 Apr; 33():28-34. PubMed ID: 28258988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
